Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:CGEM
NasdaqGS:CGEMBiotechs

Cullinan Therapeutics (CGEM): Assessing Valuation Following FDA Submission for Zipalertinib Accelerated Approval

Cullinan Therapeutics has started a rolling submission with the FDA for accelerated approval of zipalertinib, its experimental drug for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. This regulatory step follows positive results from the Phase 1/2 REZILIENT1 trial and builds on the drug’s prior Breakthrough Therapy Designation. See our latest analysis for Cullinan Therapeutics. The momentum around Cullinan Therapeutics has turned noticeably positive this month,...
LSE:TW.
LSE:TW.Consumer Durables

Are Taylor Wimpey’s Shares Poised for Recovery After Latest Housing Sector News?

Ever wondered if Taylor Wimpey is actually undervalued, or if the stock’s recent moves are a sign of something deeper? Let’s dig in to see if there’s real value here or if it’s just market noise. Shares have jumped 6.3% this week after previously dropping 4.3% over the past month, and they’re still down 15.1% year-to-date. This recent momentum is worth a closer look. Much of this fluctuation is linked to recent news around the UK housing sector, as government planning reforms and mortgage...
SZSE:002028
SZSE:002028Electrical

Global Growth Stocks Insiders Are Eager To Own

As global markets grapple with AI-related concerns and fluctuating economic indicators, investor sentiment has been cautious, particularly in tech-heavy sectors like the Nasdaq Composite. Despite these challenges, growth companies with high insider ownership often stand out as potential opportunities due to their alignment of interests between management and shareholders.